Surgical Science Sweden shares stand 72% above a director's purchase
- Insider
- Thomas Eklund
- Role
- Board member
- Company
- Surgical Science Sweden (SUS)
- Transaction
- Buy
- Shares
- 262,588
- Amount
- SEK 8.3M
- Trade date
- Nov 27, 2025
- Filed
- Nov 28, 2025, 1 day after the trade
- Source
- Finansinspektionen ↗
Surgical Science Sweden traded at SEK 58.40 at 09:54 CET on October 26, 2026 (delayed by 15 to 20 minutes). That is 72.0% above the first close after a purchase by board member Thomas Eklund, which was SEK 33.96 on Nov 28, 2025.
Thomas Eklund bought 262,588 shares at SEK 31.78 on Nov 27, 2025, for a total of SEK 8.3M. The purchase was reported to Finansinspektionen on November 28, 2025, 1 day after the trade. Measured from the first close after the filing, SEK 34.40 on Dec 1, 2025, the change is +69.8%.
When it was filed, the purchase was larger than each of the 10 earlier insider purchases of Surgical Science Sweden in our records since 2021. Before November 28, 2025, 2 holders had disclosed net short positions in the company, together 2.03%. The largest was Qube Research & Technologies Limited, at 1.38%.
No sales by Thomas Eklund in Surgical Science Sweden have been reported since. It is 333 days since the purchase.
SUS +0.9% on the day, close Oct 30